Dysbiosis of the fecal microbiota in the TNBS-induced Crohn’s disease mouse model

被引:0
|
作者
Qing He
Xiaoping Li
Chuan Liu
Lili Su
Zhongkui Xia
Xin Li
Ying Li
Lingling Li
Ting Yan
Qiang Feng
Liang Xiao
机构
[1] The Sixth Affiliated Hospital of Sun Yat-sen University,Department of Gastroenterology
[2] The Sixth Affiliated Hospital of Sun Yat-sen University,Nutrition Department
[3] BGI-Shenzhen,undefined
[4] Shenzhen Key Laboratory of Human Commensal Microorganisms and Health Research,undefined
[5] Shenzhen Engineering Laboratory of Detection and Intervention of Human Intestinal Microbiome,undefined
来源
关键词
Inflammatory bowel disease; Crohn’s disease; TNBS-induced; Fecal microbiome; Mouse model;
D O I
暂无
中图分类号
学科分类号
摘要
Crohn’s disease (CD) is characterized by chronic transmural inflammation. The symptom of the mice model induced by 2,4,6-trinitrobenzenesulfonic acid (TNBS) is closed to human under CD condition, so this kind of animal is widely used in the related researches. Although the dysbiosis of the fecal microbiota has been proved to play an important role in the patients with CD, the composition of the gastrointestinal microbiota in the mouse model under disease condition is still unclear. In the current study, male 7-week BALB/c mice were anesthetized and intrarectal administrated by ethanol (ET group), TNBS in ethanol (TN group), and phosphate buffered saline (PBS) (CK group) as control. The symptoms of individuals under the CD condition were observed, and the changes of the bacterial taxonomic structure and functional composition were revealed by next-generation sequencing (NGS) 16S sequencing. The BALB/c mice in TN group demonstrated CD-like symptoms and the damages in the intestinal tract. The NGS 16S results exhibited that the diversity and microbial composition under CD condition are significantly different with those in ET group. The KEGG Orthology (KO) profile were generated from PICRUSt, and function modules such as methanogenesis (M00347) and microcin C transport system (M00349) were found enriched in the individuals in the TN group. This study proved that mouse model induced by TNBS could develop the similar symptom to CD patient, and we firstly showed the significant intestinal microbe changes on both taxonomic structure and functional composition in this mouse model.
引用
收藏
页码:4485 / 4494
页数:9
相关论文
共 50 条
  • [21] Chronic Experimental Model of TNBS-Induced Colitis to Study Inflammatory Bowel Disease
    Silva, Ines
    Solas, Joao
    Pinto, Rui
    Mateus, Vanessa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [22] Fecal Lipocalin-2 as a Sensitive and Noninvasive Biomarker in the TNBS Crohn's Inflammatory Bowel Disease Model
    Hsieh, Heidi
    Morin, Jeffrey
    Filliettaz, Cyndi
    Varada, Rao
    LaBarre, Shelby
    Radi, Zaher
    TOXICOLOGIC PATHOLOGY, 2016, 44 (08) : 1084 - 1094
  • [23] hUC-MSCs therapy for Crohn's ' s disease: efficacy fi cacy in TNBS-induced colitis in rats and pilot clinical study
    Sun, Qinjuan
    Li, Shan
    Lin, Ritian
    Zhao, Guangxi
    Lu, Jinlai
    Liu, Bin
    Hu, Miao
    Wang, Wei
    Yang, Xiaoqing
    Wei, Yushuang
    Jia, Wenwen
    Hu, Yanni
    Zhang, Wei
    Zhu, Jiawen
    Cui, Daxiang
    Zhong, Lan
    EBIOMEDICINE, 2024, 103
  • [24] Microbiome characterization and reversal of dysbiosis in Parkinson's disease by Fecal Microbiota Transplantation
    DuPont, Herbert L.
    Suescun, Jessika
    Jiang, Zhi-Dong
    Brown, Eric L.
    Iqbal, Tehseen
    Alexander, Ashley S.
    DuPont, Andrew W.
    Newark, Michael
    Essigmann, Heather T.
    Schiess, Mya C.
    NEUROLOGY, 2020, 94 (15)
  • [25] Structural and Functional Dysbiosis of Fecal Microbiota in Chinese Patients With Alzheimer's Disease
    Ling, Zongxin
    Zhu, Manlian
    Yan, Xiumei
    Cheng, Yiwen
    Shao, Li
    Liu, Xia
    Jiang, Ruilai
    Wu, Shaochang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 8
  • [26] Pharmacologic Evaluation of Sulfasalazine, FTY720, and Anti-IL-12/23p40 in a TNBS-Induced Crohn's Disease Model
    Radi, Zaher A.
    Heuvelman, Deborah M.
    Masferrer, Jaime L.
    Benson, Ericka L.
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) : 2283 - 2291
  • [27] Pharmacologic Evaluation of Sulfasalazine, FTY720, and Anti-IL-12/23p40 in a TNBS-Induced Crohn’s Disease Model
    Zaher A. Radi
    Deborah M. Heuvelman
    Jaime L. Masferrer
    Ericka L. Benson
    Digestive Diseases and Sciences, 2011, 56 : 2283 - 2291
  • [28] Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model
    Seoane-Viano, Iria
    Gomez-Lado, Noemi
    Lazare-Iglesias, Hector
    Barreiro-de Acosta, Manuel
    Silva-Rodriguez, Jesus
    Luzardo-Alvarez, Asteria
    Herranz, Michel
    Otero-Espinar, Francisco
    Ramon Antunez-Lopez, Jose
    Jesus Lamas, Maria
    Aguiar, Pablo
    Fernandez-Ferreiro, Anxo
    Ruibal, Alvaro
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 549 (1-2) : 335 - 342
  • [29] Dysbiosis of Gut Fungal Microbiota is Associated With Mucosal Inflammation in Crohn's Disease
    Li, Qiurong
    Wang, Chenyang
    Tang, Chun
    Ms, Qin He
    Li, Ning
    Li, Jieshou
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2014, 48 (06) : 513 - 523
  • [30] Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients
    Liguori, Giuseppina
    Lamas, Bruno
    Richard, Mathias L.
    Brandi, Giovanni
    da Costa, Gregory
    Hoffmann, Thomas W.
    Di Simone, Massimo Pierluigi
    Calabrese, Carlo
    Poggioli, Gilberto
    Langella, Philippe
    Campieri, Massimo
    Sokol, Harry
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (03): : 296 - 305